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INTRODUCTION 
Incisional hernias (IH) are a frequent complication of abdominal wall incisions. They occur in 5-
20% of the general patient population [1–3]. In high-risk patients, the incidence of IH can 
increase to more than 60% [4,5]. In the emergency setting, the reported incidence of IH is 
greater than 50% [6,7]. IH can cause morbidity and have a negative effect on patients’ quality of 
life (QoL). Despite advances in IH repair, recurrence rates remain high (12–54%) [8], and those 
who experience recurrence are susceptible to a vicious cycle of complications, as each 
subsequent repair presents a greater technical challenge with an increased risk of further 
recurrence and morbidity [9]. In terms of healthcare economics, in 2011, a study from France 
has shown that if the rate of IH  after abdominal surgery could be reduced to 5%, a total of 4 
million Euros would have been saved [10]. Therefore, prevention of IH is important for both 
patients and health care providers [3]. 
Risk factors for IH development are both patient related and secondary to technical 
considerations for abdominal wall closure [11]. Some patient related risk factors can be modified 
to reduce the rate of IH, including smoking cessation, optimizing diabetic control, weight loss 
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and implementing bundles to reduce SSI. The technical considerations that can be employed to 
reduce the incidence of IH include the choice of suture material, the use of either small bites to 
close the linea alba and prophylactic mesh placement (PMP) [12].  
Previous systematic reviews and meta-analyses have shown that PMP is safe and effective at 
preventing IH [3,13]. However in the specific setting of PMP, there is minimal data on which is 
the optimal mesh composition, the best anatomical position to place the mesh within the 
abdominal wall or the best method of mesh fixation [9]. There is also fear regarding the potential 
long-term sequelae of PMP, such as chronic seroma, chronic pain, infection or mesh 
explantation. Additionally, there are no data on how to manage those patients that develop an 
IH after PMP.  
Concerned about this problem, and following our satisfactory short to mid-term results in PMP 
after midline laparotomies (ML) in colorectal surgery [14], we wanted to investigate what 
happened to patients undergoing PMP after several years. So, the aim of this study was to 
evaluate the long-term outcomes after prophylactic use of onlay mesh in ML.  
 
METHODS 
This observational study was conducted in the Department of General and Digestive Surgery of 
Henares University Hospital in Madrid, Spain, between 2008-2014. Our center is a 250-bed 
facility that belongs to the Spanish National Health Service and attends over 160,000 population 
in the periphery of Madrid, with 20% of immigrants from Eastern Europe. Surgical team 
comprises 12 surgeons with specialization in general and digestive surgery who were 
responsible for both elective and emergency operations. 
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The primary outcome of the study was to assess the long-term incidence of IH after PMP. 
Secondary outcome measures were the need for reoperation, chronic infection, chronic 
seromas, mesh explantation and chronic pain. 
From a prospective maintained database, we have identified those patients over 18 years old, 
operated by ML with PMP, in either an emergency or elective setting with a minimum follow-up 
of 2 years. The STROBE Statement recommendations were followed [15]. The decision to 
perform PMP was made by the surgeon responsible for the patient. All patients were informed 
& consented prior to surgery.  
As previously described [14], abdominal wall closure was performed by a standardised protocol 
of PMP. Briefly, the linea alba was closed with running sutures of long-term resorbable 
monofilament USP number 0 or 1, spaced 1 cm apart and 1 cm from the cut edge.  A large-pore, 
medium-density polypropylene mesh (Optilene Mesh Elastic; B. Braun, Melsungen, Germany) 
was placed in the fascial onlay position. The mesh was 5 cm wide and the length of the mesh 
was adapted to the incision with an overlap of 2 cm at both ends. The meshes were fixed to the 
anterior rectus sheath with interrupted resorbable sutures 3-4 cm apart. When an ostomy was 
placed, the mesh did not reach or cover the stoma site. The subcutaneous tissue was closed by 
interrupted polyglactin 2/0 stitches fixed to the mesh and a suction drain was left over the mesh. 
Staples were used for skin closure. 
Registered preoperative clinical data included age, sex, body mass index (BMI), American Society 
of Anesthesiologists (ASA) grade, comorbidities [hypertension, diabetes, chronic obstructive 
pulmonary disease (COPD), cardiopathy, collagen disease, etc], previous history of cancer and 
smoking. Intraoperative variables included operative status (elective or emergency), diagnosis, 
operative procedure, stoma formation and operation time. Patients who developed full 
thickness abdominal wall dehiscence (evisceration) or required further surgery within the first 
30 days post-operatively undergoing removal of the mesh without any new mesh implantation 
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were excluded from data analysis. All post-operative surgical site occurrences were included in 
the analysis. Centers for Disease Control and Prevention definitions of SSI were used [16]. 
Seroma was defined as a mass or swelling in the wound caused by the localized accumulation of 
clear serum liquid without SSI signs. Chronic pain was defined as any pain lasting more than 12 
weeks [17]. VAS score > 2 and the need for analgesia were considered as pain. Mesh explantation 
was defined as a chronic wound infection that required mesh removal.  Complications were 
diagnosed and registered by the surgeons of the department. 
Patient follow-up was carried out in the outpatient clinic by clinical examination. Incisional 
herniation was diagnosed according to EHS definition [18]. Computed tomographic (CT) scan 
was performed as part of routine surveillance for oncology patients, when there was any clinical 
uncertainty regarding the presence of an IH, and for investigation of other complaints not 
related to the previous surgery.  
The description of variables and the statistical analysis were performed using the Statistical 
Package for the Social Sciences (SPSS) program (version 19.0 for Windows). Quantitative 
variables were expressed as mean and standard deviation, and categorical variables as absolute 
numbers and percentages. The statistical analysis of the quantitative variables for independent 
groups was performed with the nonparametric Mann-Whitney U test. In the statistical analysis 
of categorical variables, the Pearson χ2 (Fisher’s) test was used. The appearance of IH during 
follow-up was analyzed with the Kaplan-Meier estimation method and comparative analysis of 
time-to-event data was performed using the log rank test. Statistical significance was accepted 





Between 2008-2014, a cohort of 172 patients underwent PMP following ML (Figure 1). These 
include 96 men (56%) and 76 women (44%), with a mean age of 68 years (62-77) and mean BMI 
of 28.6 kg/m² (25.2-30.8).  
Comorbidities (summarized in Table 1) were: smoking, 71 (41.3%) patients; heart disease, 53 
(30.8%) patients; hypertension 94 (54.7%) patients; COPD, 24 (14%) patients; diabetes, 38 
(22.1%) patients; obesity, 44 (25.6%) patients; and previous history of cancer, 34 (19.8%) 
patients. The most common indication for surgery was uncomplicated colorectal cancer (70% of 
cases). Other diagnoses included ischemia, acute diverticulitis, and bowel obstruction. 
The procedures performed included left hemicolectomy/sigmoidectomy, 45(26.2%) patients; 
right hemicolectomy, 39 (22.7%) patients; anterior resection of rectum, 30 (17.4%) patients; 
total/subtotal colectomy, 16 (9.3%) patients; small bowel resection, 9 (5.2%) patients; 
abdominoperineal resection, 8 (4.7%) patients; exploratory laparotomy, 12 (7%) patients; and 
adhesiolysis, 11 (6.4%) patients. Emergency surgery was performed in 36 (25%) patients, after 
having excluded lost of follow-up patients. 
 There were 145 (85%) patients with clean-contaminated wounds; 11 (6.4%) patients with clean 
wounds; 2 (1.2%) patients with contaminated wounds and 14 (8.1%) patients with dirty wounds. 
Twenty-nine (17%) patients were given a colostomy, of which 7 (24%) were temporary; and 19 
(11%) patients had an ileostomy, of which 13 (68.4%) were temporary. The mean postoperative 
hospital stay was 11 (range, 7-18) days.  
Related with surgical site occurrences, we registered: 17 (9.9%) patients with a superficial SSI 
(Clavien-Dindo grade I); 23 (13.4%) patients with wound seromas (Clavien-Dindo grade I); 9 
(5.2%) patients with organ/space infection (2 Clavien-Dindo grade IIIa, 2 grade IIIb, 3 grade IVa 
and 2 grade IVb); and 2 (1.1%) patients with deep SSI (Clavien-Dindo type IIIb). In these last two 
cases the mesh needed to be removed within the first six months after surgery due to chronic 
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infection (Figure 2). The bacterial wound culture isolated Pseudomonas aeruginosa and 
Escherichia Coli, respectively. 
Patients were followed up for up to 8 years in the outpatient clinic (Figure 3), with a mean follow-
up of 5 ± 1.6 years. Those patients that were not currently followed-up by the surgeon that 
performed the original surgery were invited to attend the outpatient clinic for an up-to-date 
clinical examination by the main author (CSM). Most of them have been reviewed during the 
last two years before the analysis (Figure 3). The estimated freedom from IH is shown in Figure 
4. During follow-up, a global mortality of 29 (20%) patients was registered. None of these were 
thought to be directly related to PMP. A total of 28 (16.2%) patients were lost to follow up, due 
to migration of foreign patients or other unknown reasons. Patients undergoing reoperation 
within 30 postoperative days with removal of the mesh without any new mesh implantation 
were excluded from data analysis. This included 3 (1.74%) patients with full thickness abdominal 
wall dehiscence; and 5 (2.9%) patients requiring early reoperations (2 anastomotic leaks after 
colorectal surgery, 1 intra-abdominal abscess, 1 early haemoperitoneum and 1 case of 
peritoneal carcinomatosis). Data from 144 patients were used for final analysis. 
During follow-up, 8 patients (5.55%) underwent further surgery. These included a Hartmann’s 
procedure reversal (3 patients), metachronous colon cancer (2 patients), adhesions causing 
intestinal obstruction (1 patient), gastric cancer procedure (1 patient) and urologic surgery (1 
patient). No hernia was found during these relaparotomies. A dense fibrosis was found to be 
covering the linea alba and no adhesions were found directly related to the fibrosis or mesh 
itself (Figure 5 and Video). 
After clinical and radiological examination, 13 patients were diagnosed with IH. One patient was 
diagnosed with an IH on CT after a negative clinical exam. The overall incidence of IH was 9.02% 
(13/144) (Table 2). These included 7 emergency and 6 elective cases. The incidence of IH in those 
patients requiring emergency surgery was 19.4% and 5.5% for elective surgery. In those patients 
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that developed an IH, 8 were in patients with colorectal cancer. The remaining cases include 3 
patients with non-cancer related bowel obstruction, 1 exploratory laparotomy due to sepsis 
secondary to duodenal ulcer and 1 acute diverticulitis, requiring a Hartmann’s procedure. The 
incidence of IH in non-cancer patients was 16.1% (5/31 patients) and 7% (8/113 patients) in the 
oncological group. 
In those patients that developed an IH, 5 of them (3.47%) underwent a repair by either 
retrorectus (2 patients) or component separation techniques (3 patients). There were no 
complications related to the previous mesh insertion. Even in 2 cases, the prophylactic mesh 
was not even discerned during surgical repair. The other 8 patients remain asymptomatic and 
do not want further surgery. No chronic seromas or foreign body reaction have been observed. 
None of the patients have developed chronic pain.  
In the comparative analysis, obesity was a risk factor for IH (p=0.05) (Figure 6). The incidence of 
IH was also statistically different in the operative status: 19.4 % (7/36) in emergency surgeries 
and 5.55% (6/108) in elective procedures (p=0.01; RR 4.99: 1.15-21.5). Survival plot after log-
rank test affirmed these differences (p=0.031) in operative status but not in obesity (BMI 
30)(p=0.081) (Figure 7). There were no statistical differences regarding any other preoperative, 
intraoperative or postoperative variables (Table 3). 
 
DISCUSSION 
 To date the most widely accepted, albeit still controversial, surgical techniques to reduce the 
incidence of IH are the use of small bites technique to close the linea alba [19,20] and mesh 
augmentation procedure [2]. In the latest European Hernia Society (EHS) guidelines both 
methods were given only a weak recommendation [12]. Three recent systematic reviews have 
shown that mesh prophylaxis reduces the risk of developing an IH by 85%  [9,21,22]. Subgroup 
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analyses confirmed this benefit whether the mesh was placed in an onlay, retrorectus, or 
preperitoneal location. However, there is no data available on more than 2 years follow-up. 
This study shows that the use of PMP in ML, in elective and emergency surgery, to prevent 
incisional hernias is effective and safe in the long term. At mean follow up of 5 years the 
incisional hernia rate was 5% for elective and 16% for emergency surgery, with an overall 
incidence of 9%.  
Which mesh type to use and the best anatomical layer to place the mesh within the abdominal 
wall has not been determined. We chose a very large-pore mesh because these low-density 
polypropylene meshes tolerated contaminated fields in our previous  experimental model of 
contamination [23], and was satisfactorily applied in our randomized controlled trial (RCT), 
that included patients in emergency situation and contaminated settings [14]. 
Polypropylene meshes have been commonly used to prevent IH following abdominal aortic 
aneurysm surgery, obesity surgery or colorectal surgery [24-27]. A few studies have been 
published on the use of biological, composite and biosynthetic meshes to prevent IH but 
currently there is little data to support their use [28-30]. The use of other synthetic meshes made 
from either polyester or polyvinylidene fluoride has not been described.  
In the published studies, there is no difference in surgical sites occurrences with regard to which 
layer of the abdominal wall the mesh is placed, with the exception of seroma development. This 
is observed more frequently in patients that have an onlay compared with sublay mesh 
reinforcement [3]. We present 13% cases of seromas, which are consistent with other reported 
results with rates of up to 18% [31]. There were no reported clinically relevant outcomes in 
relation to the seromas in our series. Our preference is to use a subcutaneous drain to reduce 
the incidence of seroma formation but we accept there is no clear evidence to support its use 
[32]. One study has shown that fibrin sealant may reduce seroma formation following onlay 
mesh reinforcement [33], but this was not confirmed in the PRIMA trial [3].  
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The PRIMA study, a multicentre, double-blind, randomised controlled trial, showed there was 
no difference in IH rate whether mesh was placed in the onlay or sublay position [3]. We 
recommend the onlay placement of mesh as it is less technically complex and requires less 
operative time than the sublay or preperitoneal approach. Sublay mesh placement in the 
retrorectus plane (the Rives-Stoppa technique) can pose a significant technical challenge and 
add operative time that may lead to poor uptake among surgeons in the prophylactic setting [9]. 
Prophylactic onlay mesh placement offers a relatively easy, generalizable technique for all 
patients undergoing midline laparotomy, for surgeons of all specialties, including vascular 
surgery, urology and gynaecology [3].  
Currently we use long-term resorbable sutures to fix the mesh, but accept other techniques for 
mesh fixation, such as the use of glues or staples, may have a role, particularly in reducing 
operative time. However, we do not believe their use would obtain better results in terms of 
morbidity or IH formation.  
There are concerns about the long term problems associated with mesh implantation [34]. In 
our series, there were only two cases of chronic infection requiring mesh removal. Although 
using general anesthesia, the surgical removal of the mesh was simple and did not produce IH. 
This seems a reasonable price to pay for overall IH rates under 10%. Interestingly, the use of 
PMP did not cause any problems in patients requiring surgery at a later date for other causes. 
The surgical repair of IH that developed despite PMP was not modified by the presence of the 
onlay mesh, that was not even noticed in two cases.  
One other study has reported the use of PMP in emergency surgery to prevent IH [7]. The 
authors retrospectively assessed 51 emergency operations with 1-year follow-up. They reported 
a 6% IH rate. Although our IH rate after emergency surgery was 19%, we believe this may, at 
least in part, be due to our longer follow up. On log rank testing we have shown that emergency 
surgery is a risk factor for the development of IH: 5 times higher.  
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Additionally patients with BMI equal to or higher than 27 kg/m² have a more than 30% chance 
of developing IH after ML [35]. We have also observed that a higher level of BMI is a risk factor 
for the development of IH, even when a prophylactic mesh is used. Although we accept this was 
not confirmed on log-rank testing. 
Nonetheless, our study has some important limitations. Due to our inclusion criteria we assessed 
a heterogeneous population in terms of baseline characteristics and operations performed. The 
indication to perform PMP was not standardized but based on the judgement of the surgeon 
responsible for the patient, but our data may be considered a truly representative every-day 
scenario. Another interesting point would have been to also consider the incidence of 
parastomal hernias even in case of temporary ones. We believe that future studies must take 
this into account. Assessment of IH by CT was only made in oncological patients or in case of 
clinical doubts in non-oncological. If all patients had undergone a CT scan, a slightly higher 
number of IH might have potentially been identified. Although, we did not include evaluation of 
QoL in our study, we have not found that abdominal wall pain was an impairment symptom in 
our patients. We have not considered the cost-effectiveness in our study, which would be an 
interesting point, since a recent cost-utility analysis revealed that PMP is less costly and overall 
more effective than primary suture closure [36].  
 
CONCLUSIONS  
The published data to date has shown that PMP at the time of closing midline laparotomies is 
safe and effective at reducing the rate of incisional hernias up to 2 years follow-up. This study 







DECLARATION OF CONFLICT OF INTEREST 
CS declares no conflict of interest. 
DM declares no conflict of interest. 
EJ declares no conflict of interest. 
PL declares no conflict of interest. 
AR declares no conflict of interest. 
LAB declares conflict of interest not directly related to the submitted work (GORE). 
JLM declares conflict of interest not directly related to the submitted work (GORE). 
EG declares no conflict of interest. 
CJ declares no conflict of interest. 
MAGU declares conflict of interest not directly related to the submitted work (COVIDIEN, B 
BRAUN, GORE and MEDTRONIC). 
 
Author’s contribution to the Work: 
MAGU, LAB and JLM conceived of the presented idea. MAGU, CS and DM designed the study. 
CS, EJ, CJ and PL collected data from the registry and AR verified the analytical methods. MAGU 
and EG encouraged CS, DM and EJ to investigate and supervised the findings of this work. All 










1.  Veljkovic R, Protic M, Gluhovic A, Potic Z, Milosevic Z, Stojadinovic A (2010) Prospective 
clinical trial of factors predicting the early development of incisional hernia after midline 
laparotomy. J Am Coll Surg 210(2):210–9.  
2.  Rhemtulla IA, Messa CA, Enriquez FA, Hope WW, Fischer JP (2018) Role of prophylactic 
mesh placement for laparotomy and stoma creation. Surg Clin North Am 98(3):471-481. 
3.  Jairam AP, Timmermans L, Eker HH, Pierik REGJM, van Klaveren D, Steyerberg EW, et al 
(2017) Prevention of incisional hernia with prophylactic onlay and sublay mesh 
reinforcement versus primary suture only in midline laparotomies (PRIMA): 2-year 
follow-up of a multicentre, double-blind, randomised controlled trial. Lancet 
390(10094):567–76.  
4.  Muysoms FE, Detry O, Vierendeels T, Huyghe M, Miserez M, Ruppert M, et al (2016) 
Prevention of Incisional Hernias by Prophylactic Mesh-augmented Reinforcement of 
Midline Laparotomies for Abdominal Aortic Aneurysm Treatment: A Randomized 
Controlled Trial. Ann Surg 263(4):638–45.  
5.  Alnassar S, Bawahab M, Abdoh A, Guzman R, Al Tuwaijiri T, Louridas G (2012) Incisional 
hernia postrepair of abdominal aortic occlusive and aneurysmal disease: five-year 
incidence. Vascular 20(5):273–7.  
6.  Mingoli A, Puggioni A, Sgarzini G, Luciani G, Corzani F, Ciccarone F, et al (1999) Incidence 




7.  Argudo N, Pereira JA, Sancho JJ, Membrilla E, Pons MJ, Grande L (2014) Prophylactic 
synthetic mesh can be safely used to close emergency laparotomies, even in peritonitis. 
Surgery 156(5):1238–44.  
8.  Burger JWA, Luijendijk RW, Hop WCJ, Halm JA, Verdaasdonk EGG, Jeekel J (2004) Long-
term follow-up of a randomized controlled trial of suture versus mesh repair of incisional 
hernia. Ann Surg 240(4):578-83-5.  
9.  Borab ZM, Shakir S, Lanni MA, Tecce MG, MacDonald J, Hope WW, et al (2017) Does 
prophylactic mesh placement in elective, midline laparotomy reduce the incidence of 
incisional hernia? A systematic review and meta-analysis. Surgery 161(4):1149–63.  
10.  Gillion J-F, Sanders D, Miserez M, Muysoms F (2016) The economic burden of incisional 
ventral hernia repair: a multicentric cost analysis. Hernia 20(6):819–30.  
11.  Itatsu K, Yokoyama Y, Sugawara G, Kubota H, Tojima Y, Kurumiya Y, et al (2014) Incidence 
of and risk factors for incisional hernia after abdominal surgery. Br J Surg 101(11):1439–
47.  
12.  Muysoms FE, Antoniou SA, Bury K, Campanelli G, Conze J, Cuccurullo D, et al (2015) 
European Hernia Society guidelines on the closure of abdominal wall incisions. Hernia 
19(1):1–24.  
13.  Timmermans L, de Goede B, Eker HH, van Kempen BJH, Jeekel J, Lange JF (2013) Meta-
analysis of primary mesh augmentation as prophylactic measure to prevent incisional 
hernia. Dig Surg 30(4–6):401–9.  
14.  García-Ureña MÁ, López-Monclús J, Hernando LAB, Montes DM, Valle de Lersundi AR, 
Pavón CC, et al (2015) Randomized controlled trial of the use of a large-pore 




15.  STROBE Statement: https://www.strobe-statement.org/index.php?id=strobe-home. 
Accesed 30 Oct 2017. 
16.  Berríos-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, et al (2017) 
Centers for Disease Control and Prevention Guideline for the prevention of surgical site 
infection, 2017. JAMA Surg 152(8):784.  
17.  Treede R-D, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al (2015) A classification 
of chronic pain for ICD-11. Pain 156(6):1.  
18.  Muysoms FE, Miserez M, Berrevoet F, Campanelli G, Champault GG, Chelala E, et al 
(2009) Classification of primary and incisional abdominal wall hernias. Hernia 13(4):407–
14.  
19.  Millbourn D, Cengiz Y, Israelsson LA (2009) Effect of Stitch Length on Wound 
Complications After Closure of Midline Incisions. Arch Surg 144(11):1056.  
20.  Deerenberg EB, Harlaar JJ, Steyerberg EW, Lont HE, van Doorn HC, Heisterkamp J, et al 
(2015) Small bites versus large bites for closure of abdominal midline incisions (STITCH): 
a double-blind, multicentre, randomised controlled trial. Lancet 386(10000):1254–60.  
21.  Wang X-C, Zhang D, Yang Z-X, Gan J-X, Yin L-N (2017) Mesh reinforcement for the 
prevention of incisional hernia formation: a systematic review and meta-analysis of 
randomized controlled trials. J Surg Res 209:17–29.  
22.  Payne R, Aldwinckle J, Ward S (2017) Meta-analysis of randomised trials comparing the 
use of prophylactic mesh to standard midline closure in the reduction of incisional 
herniae. Hernia 21(6):843–53.   
23.  Díaz-Godoy A, García-Ureña MA, López-Monclús J, Vega V, Melero D, Erquinigo N (2011) 




24.  Bevis PM, Windhaber RAJ, Lear PA, Poskitt KR, Earnshaw JJ, Mitchell DC (2010) 
Randomized clinical trial of mesh versus sutured wound closure after open abdominal 
aortic aneurysm surgery. Br J Surg 97(10):1497–502.  
25.  Strzelczyk JM, Szymański D, Nowicki ME, Wilczyński W, Gaszynski T, Czupryniak L (2006) 
Randomized clinical trial of postoperative hernia prophylaxis in open bariatric surgery. Br 
J Surg 93(11):1347–50.  
26.  Abo-Ryia MH, El-Khadrawy OH, Abd-Allah HS (2013) Prophylactic Preperitoneal Mesh 
Placement in Open Bariatric Surgery: a Guard Against Incisional Hernia Development. 
Obes Surg 23(10):1571–4.  
27.  Hidalgo MP, Ferrero EH, Ortiz MA, Castillo JMF, Hidalgo AG (2011) Incisional hernia in 
patients at risk: can it be prevented? Hernia 15(4):371–5.  
28.  Bali C, Papakostas J, Georgiou G, Kouvelos G, Avgos S, Arnaoutoglou E, et al (2015) A 
comparative study of sutured versus bovine pericardium mesh abdominal closure after 
open abdominal aortic aneurysm repair. Hernia 19(2):267–71.  
29.  Llaguna OH, Avgerinos D V, Nagda P, Elfant D, Leitman IM, Goodman E (2011) Does 
prophylactic biologic mesh placement protect against the development of incisional 
hernia in high-risk patients? World J Surg 35(7):1651–5.  
30.  Söderbäck H, Mahteme H, Hellman P, Sandblom G (2016) Prophylactic resorbable 
synthetic mesh to prevent wound dehiscence and incisional hernia in high-risk 
laparotomy: A pilot study of Using TIGR Matrix Mesh. Front Surg 3:28.  
31.  Timmermans L, Eker HH, Steyerberg EW, Jairam A, de Jong D, Pierik EGJM, et al (2015) 
Short-term results of a randomized controlled trial comparing primary suture with 
primary glued mesh augmentation to prevent incisional hernia. Ann Surg 261(2):276–81.  
32.  Gurusamy KS, Allen VB (2013) Wound drains after incisional hernia repair. Cochrane 
16 
 
Database Syst Rev 17 (12):CD005570. 
 
33.  Fortelny RH, Petter-Puchner AH, Glaser KS, Redl H (2012) Use of fibrin sealant 
(Tisseel/Tissucol) in hernia repair: a systematic review. Surg Endosc 26 (7):1803–12.  
34. Plencner M, East B, Tonar Z, Otáhal M, Prosecká E, Rampichová M, et al (2014) Abdominal 
closure reinforcement by using polypropylene mesh functionalized with poly-ε-
caprolactone nanofibers and growth factors for prevention of incisional hernia 
formation. Int J Nanomedicine 9:3263–77.  
35.  Seiler CM, Bruckner T, Diener MK, Papyan A, Golcher H, Seidlmayer C, et al (2009) 
Interrupted or continuous slowly absorbable sutures for closure of primary elective 
midline abdominal incisions. Ann Surg 249(4):576–82.  
36.  Fischer JP, Basta MN, Wink JD, Krishnan NM, Kovach SJ (2015) Cost-utility analysis of the 
use of prophylactic mesh augmentation compared with primary fascial suture repair in 
















































Figure 1. Flow diagram of patients. 
 
Figure 2. Case of mesh explantation: A) Chronic infection; B) Mesh exposure; C) Mesh removal; 





Figure 3. Follow-up of patients. Box-plot. 
 











Figure 5. Intraoperative findings during reoperation of a PMP patient. 
 































BMI: Body mass index  
COPD: Chronic obstructive pulmonary disease 
CT: computed tomographic scan 
IH: Incisional hernia 
ML: Midline laparotomy 
PMP: Prophylactic mesh placement 
QoL: Quality of life 
RCT: Randomized controlled trial  
RR: Risk ratio 
SPSS: Statistical Package for the Social Sciences  
SSI: Surgical site infection 
 
 
